跳至主要内容
临床试验/NCT01208467
NCT01208467已完成不适用

Validating The Prognostic Role of ATR Mutation in Patients With Endometrioid Endometrial Cancer

Gynecologic Oncology Group1 个研究点 分布在 1 个国家目标入组 2,824 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,824
试验地点
1
主要终点
ATR mutation status

研究概览

简要总结

This research study is studying prognostic biomarkers in tissue samples from patients with endometrial cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

详细描述

PRIMARY OBJECTIVES:

I. To validate the clinicopathologic associations and prognostic significance of ATR mutation in endometrioid endometrial cancer cases with defective DNA mismatch repair.

OUTLINE: This is a multicenter study.

DNA extracted from previously collected tumor samples is analyzed to validate the clinicopathologic associations and prognostic significance of ATR mutation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Women who were eligible and evaluable for the GOG-0210 molecular staging protocol in women with endometrial cancer
  • Women who were registered during the unrestricted enrollment period (through 9/23/07) will automatically qualify
  • Women who were registered during the restricted enrollment period (after 9/23/07) will only be considered if needed
  • Women who had histologically confirmed endometrioid endometrial adenocarcinoma regardless of stage or grade
  • Women who have defective DNA mismatch repair and are microsatellite instability positive (MSI+ and MSI-low)
  • Women who consented to allow their specimens and clinical data to be used for future cancer research
  • Women who have sufficient high-quality genomic DNA from tumor available for mutation analysis of ATR

排除标准

  • 未提供

结局指标

主要结局

ATR mutation status

时间窗: 1 month

Parametric and non-parametric statistical tests will be performed to evaluate the association between ATR mutation status and demographic and clinical data. Product-limit estimates according to Kaplan-Meier method will be calculated and difference between survival according to ATR mutation status will be assessed using a two sided log rank test. The predictive ability of the final model will be assessed using a concordance index (C-statistic).

Microsatellite instability (MSI)

时间窗: 1 month

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验